About: Catherine Pellat-Deceunynck

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Catherine Pellat-Deceunynck Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Pellat-Deceunynck, Catherine (19..-....) Pellat-Deceunynck, Catherine (19..-....) Pellat-Deceunynck, Catherine (19..-....)
alternative label	Deceunynck, Catherine Pellat- Pellat, Catherine Deceunynck
Life Event	http://www.idref.fr/12157122X/birth
preferred label	Pellat-Deceunynck, Catherine (19..-....)
name	Catherine Pellat-Deceunynck
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
isni:identifierValid	0000000358804135
Given name	Catherine
familyName	Pellat-Deceunynck
has biographical i...tion (Deprecated)	Médecin, chercheur au Département de Recherche en Cancérologie de l’Université de Nantes (en 2007)
gender	female
ORCID iD	0000-0002-6287-8148
Scopus ID	6603682395
is sameAs of	Pellat-Deceunynck, Catherine (19..-....) Pellat-Deceunynck, Catherine (19..-....) Pellat-Deceunynck, Catherine (19..-....) Pellat-Deceunynck, Catherine (19..-....)
is Thesis advisor of	http://www.sudoc.fr/121571327/id http://www.sudoc.fr/165646640/id Régulation de la mort et survie des plasmocytes humains normaux et de leurs équivalents tumoraux, les cellules du myélome multiple http://www.sudoc.fr/150420560/id http://www.sudoc.fr/133344843/id http://www.sudoc.fr/19743018X/id http://www.sudoc.fr/237855151/id http://www.sudoc.fr/269868526/id http://www.sudoc.fr/247014710/id http://www.sudoc.fr/223443506/id http://www.sudoc.fr/229846270/id
is Praeses of	http://www.sudoc.fr/225663600/id http://www.sudoc.fr/260071358/id
is Author of	TLR9 Ligand Induces the Generation of CD20+ Plasmablasts and Plasma Cells from CD27+ Memory B-Cells The selectivity of Marinopyrrole A to induce apoptosis in MCL1 high BCL2 low expressing myeloma cells is related to its ability to impair protein translation The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myeloma Generation and characterization of novel anti-DR4 and anti-DR5 antibodies developed by genetic immunization https://archive-ouverte.unige.ch/unige:177445#id BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment CD28, a marker associated with tumoral expansion in multiple myeloma Emergence and evolution of TP53 mutations are a key feature of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide. A Functional, New Short Isoform of Death Receptor 4 in Ewing's Sarcoma Cell Lines May be Involved in TRAIL Sensitivity/Resistance Mechanisms Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways ABT-737 is highly effective against molecular subgroups of multiple myeloma p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hell Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/ BAK hetero-complexes Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53 abnormal myeloma cells independently of the p53 pathway Allogeneic T lymphocytes as a source of peptide-dependent T cells specific for myeloma cells Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines Mcl-1L cleavage is involved in TRAIL-R1– and TRAIL-R2–mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells p53 regulates CD46 expression and measles virus infection in myeloma cells The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma. CSF1R and BTK inhibitions as novel strategies to disrupt the dialogue between mantle cell lymphoma and macrophages Osteoclasts support the survival of human plasma cells in vitro Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines. Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells Myeloma Cell Self-Renewal Depends on JAG2 Expression and Is Mediated by IGF1 or SCF Loop BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma https://archive-ouverte.unige.ch/unige:170572#id Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma The origin of the plasma-cell heterogeneity Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups Toll-like receptors: lessons to learn from normal and malignant human B cells Repression of Mcl-1 and disruption of the Mcl-1/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosis The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma https://hal.archives-ouvertes.fr/hal-04694485#id https://hal.archives-ouvertes.fr/hal-04727815#id
is primary topic of	http://www.idref.fr/12157122X
is Opponent of	http://www.sudoc.fr/189477830/id
is Thesis referee of	http://www.sudoc.fr/203910435/id http://www.sudoc.fr/252465695/id http://www.sudoc.fr/255914970/id http://www.sudoc.fr/242171869/id http://www.sudoc.fr/279084706/id

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software